Clinicians frequently must face questions from patients or family members about how long a terminally ill patient has to live. Even for the experienced clinician, end-of-life (EOL) estimates are a ...
Uncertainty of prognosis is one reason patients with hematologic malignancies receive aggressive therapy near end of life more often than those with advanced solid tumors. It is unknown whether end-of ...
Kahlon and colleagues have published important data that relates frailty with 30-day outcomes after discharge from hospital, such as readmission to hospital and death.1 We are concerned that an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results